Zheng Xingnan, Zhai Bo, Koivunen Peppi, Shin Sandra J, Lu Gang, Liu Jiayun, Geisen Christoph, Chakraborty Abhishek A, Moslehi Javid J, Smalley David M, Wei Xin, Chen Xian, Chen Zhengming, Beres Justine M, Zhang Jing, Tsao Jen Lan, Brenner Mitchell C, Zhang Yuqing, Fan Cheng, DePinho Ronald A, Paik Jihye, Gygi Steven P, Kaelin William G, Zhang Qing
Lineberger Comprehensive Cancer Center, University of North Carolina School of Medicine, Chapel Hill, North Carolina 27599, USA;
Department of Cell Biology, Harvard Medical School, Boston, Massachusetts 02115, USA;
Genes Dev. 2014 Jul 1;28(13):1429-44. doi: 10.1101/gad.242131.114.
The three EglN prolyl hydroxylases (EglN1, EglN2, and EglN3) regulate the stability of the HIF transcription factor. We recently showed that loss of EglN2, however, also leads to down-regulation of Cyclin D1 and decreased cell proliferation in a HIF-independent manner. Here we report that EglN2 can hydroxylate FOXO3a on two specific prolyl residues in vitro and in vivo. Hydroxylation of these sites prevents the binding of USP9x deubiquitinase, thereby promoting the proteasomal degradation of FOXO3a. FOXO transcription factors can repress Cyclin D1 transcription. Failure to hydroxylate FOXO3a promotes its accumulation in cells, which in turn suppresses Cyclin D1 expression. These findings provide new insights into post-transcriptional control of FOXO3a and provide a new avenue for pharmacologically altering Cyclin D1 activity.
三种EglN脯氨酰羟化酶(EglN1、EglN2和EglN3)调节缺氧诱导因子(HIF)转录因子的稳定性。然而,我们最近发现,EglN2的缺失也会以不依赖HIF的方式导致细胞周期蛋白D1的下调和细胞增殖的减少。在此我们报告,EglN2在体外和体内均可使FOXO3a的两个特定脯氨酰残基发生羟基化。这些位点的羟基化会阻止泛素特异性蛋白酶9x(USP9x)去泛素化酶的结合,从而促进FOXO3a的蛋白酶体降解。FOXO转录因子可抑制细胞周期蛋白D1的转录。无法使FOXO3a羟基化会促进其在细胞内的积累,进而抑制细胞周期蛋白D1的表达。这些发现为FOXO3a的转录后调控提供了新见解,并为通过药理学手段改变细胞周期蛋白D1的活性提供了新途径。